Accedi a banche dati online | Convegnodetail
mail
Anteprima di stampa
 
 

2nd Next-Generation Conjugates Summit

Evvnt Promotion / evvnt
-
21.02.2023 - 23.02.2023  Hilton Boston Logan Airport, One Hotel Drive, 02128 Boston, Massachusetts, USA
Time: 09:00 to 17:00
 
Temi della conferenza
With numerous novel conjugate companies recently receiving their INDs to enter the clinic including Avidity Biosciences and Dyne Therapeutics and many more following closely in their footsteps, conjugate drugs comprising of novel payloads and targeting formats are being thrust centre stage within the bioconjugate world.
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/1400588-3?pid=4832

Speakers: Christian Marsolais, Senior Vice President and Chief Medical Officer, Theratechnologies Inc., Fu-An Kang, Vice President, Research, MiRecule Inc., and more
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/1400588-2?pid=4832
Ms. Jessica Durston
 
Categorie
Medicina General
Lingua
Inglese
Quote del Congresso
Drug Developer Pricing - Conference + Workshop Day: USD 4197.00, Drug Developer Pricing - Conference Only: USD 2999.00, Service Provider Pricing - Conference + Workshop Day: USD 4997.00, Service Provider Pricing - Conference Only: USD 3599.00
I partecipanti attesi
1000 - 1000
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

Center of ExcellenceÄrztekammer für WienEuropean Health Forum GasteinCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioÄrzte der WeltHilfswerk AustrianewTreeAlumni Club Medizinische Universität Wien